1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Dr. Agarwal'S Eye Hospital Limited

Dr. Agarwal'S Eye Hospital Limited

5,055.50
INR
+96.50
(+1.95%)
Dr. Agarwal'S Eye Hospital Limited
NSE:DRAGARWQ
(National Stock Exchange of India)

Recent

price

5,055.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
228.34
230
241.15
243.1
251.39
290.55
316.05
326.22
360.42
372.86
296.94
427.57
567.51
673.49
838.09
984.93
- -
Revenue per Share
4.55
3.55
6.98
5.25
12.12
0.08
15.61
14.42
25.35
29.11
-3.06
51.28
78.55
98.64
116.28
147.02
- -
Basic EPS, GAAP
15.35
16.8
11.7
2.62
12.59
36.94
24.68
15.18
0.58
45.7
48.28
21.17
-2.6
191
199.06
304.4
- -
Free Cash Flow per Basic Share
0.94
-0.94
- -
1.46
1.42
1.44
0.93
1.78
1.44
1.81
0.08
0.04
3
5.49
5
6.48
- -
Dividend per Share
25.61
29.17
34.75
40.37
50.55
48.48
62.56
74.59
97
119.36
116.3
166.32
241.15
334.36
445.98
716.56
- -
Book Value per Share
22.05
26.11
32.2
38.62
49.22
48.21
61.73
67.28
91.94
38
115
162.81
238.72
332.66
386.21
659.2
- -
Tangible Book Value per Share
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Basic Weighted Avg Shares
1,028
1,035
1,085
1,127
1,182
1,366
1,485
1,533
1,694
1,752
1,396
2,010
2,667
3,165
3,939
4,696
- -
Sales/Revenue/Turnover
7.69
6.86
7.21
6.36
7.32
6.27
10.3
9.49
11.54
15.08
7.72
19.04
21.17
20.86
20.65
21.73
- -
Operating Margin (%)
64
57
54
60
62
114
87
98
109
212
191
204
202
266
395
456
- -
Depreciation Expense
20
16
31
24
57
- -
73
68
119
137
-14
241
369
464
547
701
- -
Net Income, GAAP
43.32
45.31
29.2
34.61
- -
- -
33.14
49.29
31.62
31.38
125.09
25.41
25.26
25.53
22.7
25.11
- -
Effective Tax Rate (%)
1.99
1.54
2.89
2.16
4.82
0.03
4.94
4.42
7.03
7.81
-1.03
11.99
13.84
14.65
13.87
14.93
- -
Profit Margin (%)
-85
-104
-126
-128
-81
-107
-75
-142
-55
-97
-45
-33
-85
-209
-323
252
- -
Working Capital
193
147
124
120
148
175
129
53
131
419
485
1,771
2,137
2,481
3,056
2,959
- -
LT Debt
115
131
156
190
238
228
294
351
456
561
547
782
1,133
1,572
2,096
3,463
- -
Total Equity
9.21
7.65
13.78
12.2
- -
- -
18.64
14.42
22.55
20.11
-2.53
14.76
13.79
12.78
12.97
12.5
- -
Return on Invested Capital (%)
10.4
9.64
14.38
12.22
- -
- -
18.01
15.29
22.02
20.22
-2.5
14.56
13.61
13.4
13.27
13
- -
Return on Capital (%)
18.95
12.97
21.83
14.05
26.67
0.16
28.12
21.02
29.55
26.91
-2.6
36.29
38.56
34.28
29.8
25.22
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
302
- -
LT Borrowings
- -
671
- -
LT Finance Leases
- -
2,288
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
- -
- -
24,619

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
1,365
- -
Cash, Cash Equivalents & STI
- -
957
- -
Accounts Receivable, Net
- -
187
- -
Inventories
- -
141
- -
Total Current Liabilities
- -
1,114
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
302
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
32.41%
45.05%
65.21%
Free Cash Flow
5.89%
-1,513.45%
55.13%
Net Income, GAAP
1,821.76%
-330.06%
28.27%
Sales/Revenue/Turnover
14.46%
27.81%
19.22%
Total Cash Common Dividend
697.73%
1,402.29%
31.49%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1,000
1,022
951
998
3,939
2026
1,169
- -
1,162
1,200
4,696
2027
1,430
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
30.02
30.11
22.13
34.02
116.28
2026
36.72
- -
35.76
33.6
147.02
2027
48.38
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
5
2026
- -
- -
- -
- -
6.48
2027
- -
- -
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Dr. Agarwal's Eye Hospital Limited operates primarily in the healthcare sector, specializing in ophthalmology services and eye care. The company offers a comprehensive range of ophthalmic services including cataract surgery, refractive surgery, glaucoma treatment, corneal transplants, retinal care, pediatric ophthalmology, and diabetic retinopathy management. It also provides diagnostic services and clinical consultations through its network of eye care hospitals and clinics. Founded in 1984 and headquartered in Chennai, India, Dr. Agarwal's Eye Hospital has expanded its geographic footprint across India and internationally with operations in the UAE, Africa, and other regions, aiming to provide quality eye care through technologically advanced medical practices. The company’s target markets encompass patients requiring specialized eye treatments, spanning from routine eye care to complex surgeries. Recent major developments include expansion through new hospital openings and digital health initiatives to enhance patient care access. The company has also engaged in strategic partnerships to integrate tele-ophthalmology services and launched advanced diagnostic and surgical service offerings, reflecting a strategic focus on leveraging technology to broaden service reach and improve clinical outcomes. As a leading eye care provider, Dr. Agarwal's Eye Hospital Limited focuses on delivering comprehensive ophthalmic care, supported by advanced technology and a growing network of specialized facilities, establishing itself as a key player in the eye healthcare sector across multiple geographies.